Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever

Bosnian Journal of Basic Medical Sciences

Volumn 13, Issue 1, 2013, Pages 21-26

  Sari, Ismail ^a   Bakir, Sevtap ^a   Engin, Aynur ^a   Aydin, Hüseyin ^a   Poyraz, Ömer ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Acute phase reactant; Cholesterol; Crimean Congo hemorrhagic fever disease; Serum Amyloid A

Indexed keywords

EID: 84875163094     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2013.2408     Document Type: Article

References (36)

1. Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Research 2008; 78: 125-131.
2. World Health Organization (WHO), Crimean-Congo haemorrhagic fever; Available at: http://www.who.int/csr/disease/crime-an_congoHF/en/, [accessed, January 14, 2011.]
3. Mardani M, Keshtkar-Jahromi M. Crimean-Congo hemorrhagic fever. Arch Iran Med 2007; 10: 204-214
4. Connolly-Andersen MC, Douagi I, Kraus AA, Mirazimi A. Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology 2009; 390: 157-162.
5. Cray C, Zaias J, Altman NH. Acute Phase Response in Animals: a review. Comp. Med 2009; 59(6): 517-526.
6. Jain S, Gautam V, Naseem S. Acute-phase proteins: As diagnostic tool. J Pharm Bioallied Sci. 2011; 3(1): 118-127.
7. Ahmed MS, Jadhav AB, Hassan A, Meng QH. Acute Phase Reactants as Novel Predictors of Cardiovascular Disease. ISRN Inflammation 2012; Article ID 953461
8. Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation. NEJM 1999; 340: 448.
9. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999; 265: 501-523.
10. Kushner I. The phenomenon of the acut phase response. Ann. N.Y. Acad. Sci. 1982; 389: 39-45.
11. Sodin-Semrl S, Zigon P, Cucnik S, Kveder T, Blinc A, Tomsic M, Rozman B. Serum amyloid A in autoimmune thrombosis. Autoimmun Rev 2006; 6: 21-27.
12. Jovanovic DB. Clinical importance of determination of serum amyloid A. Srp Arh Celok Lek 2004; 132: 267-71.
13. Casl MT, Sabljar-Matovinović M, Kovacević S, Pocanić D, Preden-Kereković V, Jagarinec N. Clinical relevance of serum amyloid A protein monitoring in urinary tract infections. Ann Clin Biochem 1993; 30 (Pt 3): 272-277.
14. Celik VK, Sari I, Bakir S, Engin A, Bakir D, Sari M, Poyraz O, Yildiz G. Erythrocyte Sedimentation Rate, Serum Amyloid A and C reactive Protein Levels in Patients with Acute Brucellosis. Pak J Med Sci 2011; 27(4): 823-826.
15. Jahangiri A. HDL and the acute phase response. Curr Opin Endocrinol Diabetes Obes 2010; 17(2): 156-160.
16. Cabana VG, Feng N, Reardon CA, Lukens J, Webb NR, de Beer FC, et al. Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro. J Lipid Res 2004;45: 317-25.
17. Fyfe AI, Rothenberg LS, DeBeer FC, Cantor RM, Rotter JI, Lusis AJ. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 1997; 96: 2914-2919.
18. Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high dencity lipoprotein's cellular affinity. Lab Invest 1992; 66: 778.
19. Van der Westhuyzen DR, de Beer FC, Webb NR. HDL cholesterol transport during inflammation. Curr Opin Lipidol 2007; 18: 147-151.
20. Poitou C, Divoux A, Faty A, Tordjman J, Hugol D, Aissat A, et al. Role of serum amyloid a in adipocyte-macrophage cross talk and adipocyte cholesterol efflux. J Clin Endocrinol Metab 2009; 94: 1810-1817.
21. Olsson M, Ahlin S, Olsson B, Svensson PA, Ståhlman M, Bore'n J, Carlsson LMS, Sjöholm K. Establishment of a Transgenic Mouse Model Specifically Expressing Human Serum Amyloid A in Adipose Tissue. Plos one 2011; 6: 1-8.
22. Yamada T. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med 1999; 37 (4): 381-388.
23. Hartmann A, Eide TC, Fauchald P, Bentdal O, Herbert J, Gallimore JR, et al. Serum amiloid A protein is a clinically useful indicator of renal allograft rejection. Nephrol Dial Transplant 1997; 12: 161.
24. Simon M, Johansson C, Mirazimi A. Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH-and cholesterol dependent. J Gen Virol. 2009; 90 (Pt 1): 210-215.
25. Yapar M, Aydogan H, Pahsa A, Besirbellioglu BA, Bodur H, Basustaoglu AC, et al. Rapid and quantitative detection of Crimean-Congo hemorrhagic fever virus by one-step real-time reverse transcriptase-PCR. Jpn J Infect Dis. 2005; 58(6): 358-362.
26. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean/Congo hemorrhagic fever. Rev Infect Dis. 1989; 11: 794-800.
27. Invitrogen, SAA Human ELISA Kit; Available at: http://products. invitrogen.com/ivgn/product/KHA0011?ICID=search kha0011, [accessed on July 13, 2011.]
28. Montagne P, Laroche P, Cuilliere ML, Varcin P, Duheille J. Microparticle-enhanced nephelometric immunoassay for human Creactive protein. J Clin Lab Anal 1992; 6(1): 24-29.
29. Centers for Disease Control and Prevention, Infection Control for Viral Hemorrhagic Fevers; Available at: http://www.cdc.gov/ ncidod/dvrd/spb/mnpages/dispages/cchf.htm, [accessed on January 18, 2011.]
30. Gelişim Ti{dotless}p laboratuarlari{dotless}, Kene Isi{dotless}ri{dotless}klari{dotless}yla Bulaşan Hastali{dotless}klar ve Ki{dotless}ri{dotless}m-Kongo Kanamali{dotless} Ateşi; Available at: http://www.gelisimti-plab.com/icerikg.asp?id=685, [accessed on January 18, 2011.]
31. Marmara Üniversitesi Hastanesi, Ki{dotless}ri{dotless}m Kongo Kanamali{dotless} Ateşi; Available at: http://www.hastane.marmara.edu.tr/duyuru/95/kirim-kongo-kanamali-atesi, [accessed on June 29, 2010.]
32. Whicher JT, Chambers RE, Higginson J, Nashef L, Higgins PG. Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza. J Clin Pathol 1985; 38(3): 312-316.
33. Shainkşn-Kestenbaum R, Zimlichman S, Winikoff Y, Pras M, Chaimovitz C, Sarov I. Serum amyloid A (SAA) in viral infection: rubella, measles and subacute sclerosing panencephalitis (SSPE). Clin Exp Immunol 1982; 50(3): 503-506.
34. Miwata H, Yamada T, Okada M, Kudo T, Kimura H, Morishima T. Serum amyloid A protein in acute viral infections. Arch Dis Child 1993; 68 (2): 210-214.
35. van Leeuwen HJ, Heezius ECJM, Dallinga GM, van Strijp JAG, Verhoef J, van Kessel KPM. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003; 31: 1359-1366.
36. Casl MT, Surina B, Glojnaric-Spasic I, Pape E, Jagarinec N, Kranjcević S. Serum amyloid A protein in patients with acute miyocardial infarction. Ann Clin Biochem 1995; 32: 196-200.